Tempest Therapeutics Investor Relations Material
Latest events
Study Result
Tempest Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Tempest Therapeutics Inc
Access all reports
Tempest Therapeutics Inc. is a clinical-stage biotechnology firm dedicated to developing small molecule therapeutics aimed at treating cancer. Their approach involves mechanisms that not only directly kill tumor cells but also activate tumor-specific immunity. The company is headquartered in Brisbane, California, and its shares are listed on the NASDAQ.
Key slides for Tempest Therapeutics Inc
Corporate Presentation
Tempest Therapeutics Inc
Corporate Presentation
Tempest Therapeutics Inc
Latest articles
Dick Smith: The Orchestrator of General Cinema's Expansion
Explore the genius of Dick Smith in revolutionizing General Cinema, as highlighted in “The Outsiders”.
8 May 2024
Alex Karp: The Unconventional Tech Visionary
Explore how Alex Karp's unique blend of ethical leadership and personal well-being shapes his role as CEO of Palantir Technologies.
8 May 2024
From Timber to Luxury: The Story of François-Henri Pinault and Kering
Dive into the story of François-Henri Pinault, from his rise in the family timber business to leading Kering into a global luxury powerhouse.
7 May 2024
Ticker symbol
Country
🇺🇸 United States